Compounds > zoledronic acid
Page last updated: 2024-08-25

zoledronic acid and Pseudarthrosis

zoledronic acid has been researched along with Pseudarthrosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, TL; Deo, N; Little, DG; Mikulec, K; Peacock, L; Schindeler, A1
Bobyn, J; Kathy, M; Little, DG; Rasch, A; Schindeler, A1
Baldock, PA; Birke, O; Little, DG; Morse, A; Ruys, A; Schindeler, A; Yu, NY1

Other Studies

3 other study(ies) available for zoledronic acid and Pseudarthrosis

ArticleYear
Improved union and bone strength in a mouse model of NF1 pseudarthrosis treated with recombinant human bone morphogenetic protein-2 and zoledronic acid.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2018, Volume: 36, Issue:3

    Topics: Animals; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bony Callus; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Genes, Neurofibromatosis 1; Mice; Neurofibromatosis 1; Pseudarthrosis; Recombinant Proteins; Transforming Growth Factor beta; Zoledronic Acid

2018
Maximizing bone formation in posterior spine fusion using rhBMP-2 and zoledronic acid in wild type and NF1 deficient mice.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2014, Volume: 32, Issue:8

    Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Bone Resorption; Diphosphonates; Imidazoles; Mice; Mice, Knockout; Neurofibromatosis 1; Neurofibromin 1; Osteogenesis; Pseudarthrosis; Recombinant Proteins; Spinal Fusion; X-Ray Microtomography; Zoledronic Acid

2014
Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate.
    The Journal of bone and joint surgery. British volume, 2011, Volume: 93, Issue:8

    Topics: Animals; Bone Density Conservation Agents; Bone Morphogenetic Protein 2; Combined Modality Therapy; Diphosphonates; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fracture Fixation, Internal; Fracture Healing; Fractures, Ununited; Imidazoles; Mice; Mice, Knockout; Neurofibromatosis 1; Postoperative Care; Pseudarthrosis; Recombinant Proteins; Tibial Fractures; Treatment Outcome; X-Ray Microtomography; Zoledronic Acid

2011